Cargando…

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Ye, Liang, Yang, Zhen-Hua, Fang, Su-Rong, Gu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520573/ https://www.ncbi.nlm.nih.gov/pubmed/28685736 http://dx.doi.org/10.4103/0366-6999.209887

Ejemplares similares

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
por: Powell, Steven F, et al.
Publicado: (2009)

Single pemetrexed is noninferior to platinum-based pemetrexed doublet as first-line treatment on elderly Chinese patients with advanced nonsquamous nonsmall cell lung cancer
por: Pu, Xiaolin, et al.
Publicado: (2017)

Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status
por: Yu, Xiaoqing, et al.
Publicado: (2019)

Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
por: Pandey, Avinash Vijaykumar, et al.
Publicado: (2015)

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma
por: Wang, Jia-Ni, et al.
Publicado: (2021)

Clinical Analysis of Uncommon Epidermal Growth Factor Receptor Mutations in 16 Cases of Nonsmall Cell Lung Cancer
por: Hu, Ai-Min, et al.
Publicado: (2018)

Mass-forming ischemic colitis that mimics colon cancer
por: Kim, Ho Seung, et al.
Publicado: (2020)

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
por: Garrido, Pilar, et al.
Publicado: (2017)

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis
por: Zhang, Zhonghan, et al.
Publicado: (2019)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
por: Lin, Zhong, et al.
Publicado: (2017)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Genetic Variations in Key MicroRNAs are Associated With the Survival of Nonsmall Cell Lung Cancer
por: Wu, Shuangshuang, et al.
Publicado: (2015)

Traditional Chinese medicine-induced treatment in colitis-associated colorectal cancer
por: Yang, Yuewen, et al.
Publicado: (2023)

Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung Cancer
por: Sandoval, Leticia, et al.
Publicado: (2023)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

Smoldering Multiple Myeloma Arising in Ulcerative Colitis
por: Yang, Xue, et al.
Publicado: (2018)

A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancer
por: Cui, Guanghui, et al.
Publicado: (2017)

Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
por: Zhang, Xiaojun, et al.
Publicado: (2017)

Radiofrequency Ablation Combined with Radioactive Seed Implantation for Nonsmall Cell Lung Cancer
por: Chen, Su, et al.
Publicado: (2022)

Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer
por: Lei, Weijie, et al.
Publicado: (2017)

Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications
por: Wong, Kit Yee, et al.
Publicado: (2022)

The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population
por: Li, Chuanyin, et al.
Publicado: (2018)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
por: Miyazaki, Kunihiko, et al.
Publicado: (2018)

Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)

How to handle oligometastatic disease in nonsmall cell lung cancer
por: Eichhorn, Florian, et al.
Publicado: (2021)

Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
por: Crinò, Lucio, et al.
Publicado: (2014)

New developments in locally advanced nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
por: Miao, Jian-Long, et al.
Publicado: (2016)

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021)

CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study
por: Zhao, Tongwei, et al.
Publicado: (2016)

Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer
por: Zhao, Hua-Ye, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9enc09pqu52t64d4op1ugnkspu